DE69829763D1 - Verwendung von tetrahydolipstatin in der behandlung von diabetes typ ii - Google Patents

Verwendung von tetrahydolipstatin in der behandlung von diabetes typ ii

Info

Publication number
DE69829763D1
DE69829763D1 DE69829763T DE69829763T DE69829763D1 DE 69829763 D1 DE69829763 D1 DE 69829763D1 DE 69829763 T DE69829763 T DE 69829763T DE 69829763 T DE69829763 T DE 69829763T DE 69829763 D1 DE69829763 D1 DE 69829763D1
Authority
DE
Germany
Prior art keywords
tetrahydolipstatin
treatment
diabetes type
diabetes
type
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69829763T
Other languages
English (en)
Other versions
DE69829763T2 (de
Inventor
Brian Hauptman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21894047&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69829763(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of DE69829763D1 publication Critical patent/DE69829763D1/de
Publication of DE69829763T2 publication Critical patent/DE69829763T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
DE69829763T 1997-02-05 1998-01-29 Verwendung von tetrahydolipstatin in der behandlung von diabetes typ ii Expired - Lifetime DE69829763T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3738397P 1997-02-05 1997-02-05
US37383P 1997-02-05
PCT/EP1998/000468 WO1998034630A1 (en) 1997-02-05 1998-01-29 Use of gastrointestinal lipase inhibitors

Publications (2)

Publication Number Publication Date
DE69829763D1 true DE69829763D1 (de) 2005-05-19
DE69829763T2 DE69829763T2 (de) 2006-04-13

Family

ID=21894047

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69829763T Expired - Lifetime DE69829763T2 (de) 1997-02-05 1998-01-29 Verwendung von tetrahydolipstatin in der behandlung von diabetes typ ii

Country Status (28)

Country Link
US (1) US6147108A (de)
EP (1) EP1017408B1 (de)
JP (1) JP2001509173A (de)
KR (1) KR100479968B1 (de)
CN (1) CN1154505C (de)
AR (1) AR011106A1 (de)
AT (1) ATE292975T1 (de)
AU (1) AU740375B2 (de)
BR (1) BR9807655A (de)
CA (1) CA2278854C (de)
CZ (1) CZ295567B6 (de)
DE (1) DE69829763T2 (de)
DK (1) DK1017408T3 (de)
ES (1) ES2239799T3 (de)
HK (1) HK1025251A1 (de)
HU (1) HU230834B1 (de)
ID (1) ID22650A (de)
IL (1) IL131007A0 (de)
ME (1) ME00578A (de)
NO (1) NO324452B1 (de)
NZ (1) NZ336755A (de)
PL (1) PL191222B1 (de)
PT (1) PT1017408E (de)
RU (1) RU2201272C2 (de)
TR (1) TR199901853T2 (de)
WO (1) WO1998034630A1 (de)
YU (1) YU34199A (de)
ZA (1) ZA98753B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1017408E (pt) * 1997-02-05 2005-07-29 Hoffmann La Roche Utilizacao de tetra-hidrolipstatina no tratamento de diabetes de tipo ii
AR025587A1 (es) * 1999-09-13 2002-12-04 Hoffmann La Roche Formulaciones en dispersion que contienen inhibidores de lipasa
AR025609A1 (es) 1999-09-13 2002-12-04 Hoffmann La Roche Formulaciones lipidas solidas
ES2324280T3 (es) 2000-03-14 2009-08-04 Unilever N.V. Dominios variables de la cadena pesada de anticuerpos frente a lipasas dieteticas humanas y sus usos.
US6828297B2 (en) * 2001-06-04 2004-12-07 Nobex Corporation Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US7053080B2 (en) * 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
US9174176B2 (en) * 2003-01-09 2015-11-03 Disperse Systems, Inc. Ultrasonic dispersion apparatus, system, and method
US7510849B2 (en) * 2004-01-29 2009-03-31 Glucolight Corporation OCT based method for diagnosis and therapy
US7875700B2 (en) 2004-07-19 2011-01-25 Biocon Limited Cation complexes of insulin compound conjugates, formulation and uses thereof
US7254429B2 (en) 2004-08-11 2007-08-07 Glucolight Corporation Method and apparatus for monitoring glucose levels in a biological tissue
US8036727B2 (en) 2004-08-11 2011-10-11 Glt Acquisition Corp. Methods for noninvasively measuring analyte levels in a subject
EP1874178A4 (de) 2005-04-13 2009-12-09 Glucolight Corp Verfahren zur datenreduzierung und kalibrierung eines blutzuckermonitors auf oct-basis
US8217025B2 (en) * 2006-11-17 2012-07-10 Harbor Therapeutics, Inc. Drug screening and treatment methods
DE602007008567D1 (de) * 2007-09-12 2010-09-30 Mader S R L Pharmazeutische Zusammensetzungen zur oralen Verabreichung bei der Behandlung von Adipositas-Patienten
WO2009050720A1 (en) * 2007-10-15 2009-04-23 Inventis Dds Pvt Limited Pharmaceutical composition of orlistat
MX2010003979A (es) 2007-10-16 2010-06-02 Biocon Ltd Composicion farmaceutica oralmente administrable y proceso para su preparacion.
US8571617B2 (en) 2008-03-04 2013-10-29 Glt Acquisition Corp. Flowometry in optical coherence tomography for analyte level estimation
US8309107B2 (en) * 2008-10-06 2012-11-13 Banner Pharmacaps, Inc. Stable solutions of orlistat for pharmaceutical dosage forms
FR3017536B1 (fr) * 2014-02-18 2017-05-26 Univ La Rochelle Compositions pour la prevention et/ou le traitement de pathologies liees a l'alpha-glucosidase
JP2019515654A (ja) * 2016-03-16 2019-06-13 ザ ジェイ． デヴィッド グラッドストーン インスティテューツ 肥満及び／又は糖尿病を処置するための方法及び組成物、並びに候補処置薬剤を識別するための方法及び組成物
US20190022061A1 (en) * 2017-07-21 2019-01-24 Kieu Hoang Statins (Atorvastatin) can lower blood sugar level in diabetic

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1247547A (en) * 1983-06-22 1988-12-28 Paul Hadvary Leucine derivatives
CA1328881C (en) * 1984-12-21 1994-04-26 Pierre Barbier Process for the manufacture of oxetanones
CA1270837A (en) * 1984-12-21 1990-06-26 Hoffmann-La Roche Limited Oxetanones
CA2035972C (en) * 1990-02-23 2006-07-11 Martin Karpf Process for the preparation of oxetanones
US5298497A (en) * 1990-05-15 1994-03-29 E. R. Squibb & Sons, Inc. Method for preventing onset of hypertension employing a cholesterol lowering drug
US5190970A (en) * 1990-10-19 1993-03-02 E. R. Squibb & Sons, Inc. Method for preventing onset of or treating Type II diabetes employing a cholesterol lowering drug alone or in combination with an ace inhibitor
US5130333A (en) * 1990-10-19 1992-07-14 E. R. Squibb & Sons, Inc. Method for treating type II diabetes employing a cholesterol lowering drug
US5345056A (en) * 1991-12-12 1994-09-06 Motorola, Inc. Plasma based soldering by indirect heating
CA2098167C (en) * 1992-06-24 2006-12-19 Dorothea Isler Foodstuffs and feedstuffs containing a lipase inhibitor
TW381025B (en) * 1993-08-05 2000-02-01 Hoffmann La Roche Pharmaceutical composition containing a glucosidase inhibitor and a lipase inhibitor
JP3532999B2 (ja) * 1995-03-24 2004-05-31 株式会社ロッテ 新規なタンニン類およびこれを有効成分とするリパーゼ阻害剤
JPH09227398A (ja) * 1996-02-20 1997-09-02 Zeria Pharmaceut Co Ltd 抗肥満剤
US6004996A (en) * 1997-02-05 1999-12-21 Hoffman-La Roche Inc. Tetrahydrolipstatin containing compositions
PT1017408E (pt) * 1997-02-05 2005-07-29 Hoffmann La Roche Utilizacao de tetra-hidrolipstatina no tratamento de diabetes de tipo ii

Also Published As

Publication number Publication date
PL191222B1 (pl) 2006-03-31
ES2239799T3 (es) 2005-10-01
PT1017408E (pt) 2005-07-29
DK1017408T3 (da) 2005-08-01
CN1154505C (zh) 2004-06-23
DE69829763T2 (de) 2006-04-13
TR199901853T2 (xx) 1999-12-21
NO993717L (no) 1999-10-04
AU740375B2 (en) 2001-11-01
ATE292975T1 (de) 2005-04-15
CZ295567B6 (cs) 2005-08-17
HK1025251A1 (en) 2000-11-10
NZ336755A (en) 2001-06-29
YU34199A (sh) 2002-08-12
EP1017408B1 (de) 2005-04-13
CA2278854C (en) 2014-03-04
PL334975A1 (en) 2000-03-27
CA2278854A1 (en) 1998-08-13
WO1998034630A1 (en) 1998-08-13
US6147108A (en) 2000-11-14
BR9807655A (pt) 2000-02-15
ID22650A (id) 1999-12-02
KR100479968B1 (ko) 2005-03-30
JP2001509173A (ja) 2001-07-10
AU6616998A (en) 1998-08-26
AR011106A1 (es) 2000-08-02
KR20000070733A (ko) 2000-11-25
NO993717D0 (no) 1999-07-30
CZ265199A3 (cs) 2000-02-16
HUP0001014A3 (en) 2000-12-28
IL131007A0 (en) 2001-01-28
HU230834B1 (hu) 2018-07-30
CN1246798A (zh) 2000-03-08
ZA98753B (en) 1998-08-05
RU2201272C2 (ru) 2003-03-27
HUP0001014A2 (hu) 2000-08-28
ME00578A (en) 2011-12-20
EP1017408A1 (de) 2000-07-12
NO324452B1 (no) 2007-10-22

Similar Documents

Publication Publication Date Title
DE69829763D1 (de) Verwendung von tetrahydolipstatin in der behandlung von diabetes typ ii
DE69817446D1 (de) Behandlung von diabetes
DE69941566D1 (de) N-acetylhomotaurinate zur verwendung in der behandlung von hyperkinesie
ATE355840T1 (de) Behandlung der diabetes mit thiazolidindione und metformin
ATE298241T1 (de) Behandlung von atemstillstand im schlaf
DE69631157D1 (de) Pharmazeutische Zubereitung zur Verwendung in der Behandlung von Diabetes
DE69807476D1 (de) Behandlung von schweren aromaten
ATE110556T1 (de) Verbesserungen bei der behandlung von zähnen.
EE9900345A (et) Sulfonüülkarbamiidi ja glitasooni sünergistilised kombinatsioonid diabeedi raviks
DE69905906D1 (de) Kombination von zwei oder mehreren wirkstoffen unter verwendung von mikrokapsel-formulierungen
DE50012379D1 (de) Verwendung von nanoskaligen antischuppenwirkstoffen
DE69804659D1 (de) 21-hydro-6,19-oxidoprogesterone (21oh-60p) und deren verwendung als arzneimittel zur behandlung von glukokortikoidüberschuss
DE59915061D1 (de) Herstellung von strukturierten elektroden
DE69123178T2 (de) Verwendung von Uridin zur pharmakologischen Behandlung der peripheren Komplikationen bei Diabetes
DE69534632T2 (de) Clotrimazol-Metaboliten bei der Behandlung von Sichelzellenkrankheit
DE59810482D1 (de) Schleifen von garnituren
DE69618264T2 (de) Verbesserungen bei der Herstellung von Kristallsubstraten
DE69924488D1 (de) Verwendung von optisch reinem (-) norcisapride in der behandlung des reizdarmsyndroms
ATE366577T1 (de) Behandlung der diabetes mit thiazolidindione und sulphonylurea
DE69837089D1 (de) Behandlung der diabetes mit thiazolidindione und sulphonylurea
DE59812720D1 (de) Verwendung von phytostenol enthaltender wirkstoffmischungen zur herstellung von hypocholesterinämischen mitteln
DE990441T1 (de) Arzneimittel zur behandlung von diabetischer nephrosis
DE59804303D1 (de) Herstellung von Polyenaldehyden
DE69811864D1 (de) Herstellung von bandförmigen werkstücken
DE69802300T2 (de) Behandlung von schädlichen flüssigkeiten

Legal Events

Date Code Title Description
8363 Opposition against the patent